OptimizeRx (OPRX) Non-Current Debt (2010 - 2026)

OptimizeRx has disclosed Non-Current Debt across 6 years of filings, most recently posting $19.7 million for Q2 2026.

• In Q2 2026, Non-Current Debt fell 32.78% year-over-year to $19.7 million; the TTM figure through Jun 2026 stood at $19.7 million (down 32.78% YoY), while the FY2025 annual figure was $26.3 million, down 23.33% from the prior year.
• Non-Current Debt came in at $19.7 million for Q2 2026 at OptimizeRx, down from $23.6 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $34.3 million in Q4 2024 to a low of $19.7 million in Q2 2026.
• Average Non-Current Debt over 4 years is $29.8 million, with a median of $32.3 million recorded in 2024.
• Year-over-year, Non-Current Debt gained 4.25% in 2025 and sank 32.78% in 2026.
• Over 4 years, Non-Current Debt stood at $34.2 million in 2023, then advanced by 0.17% to $34.3 million in 2024, then dropped by 23.33% to $26.3 million in 2025, then dropped by 25.11% to $19.7 million in 2026.
• Per Business Quant data, the three most recent Non-Current Debt figures were $19.7 million in Q2 2026, $23.6 million in Q1 2026, and $26.3 million in Q4 2025.